{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-021201","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2023-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.031024+00:00","generated_at":"2026-06-12T21:41:50.048600+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Diffusion Pharmaceuticals appoints Jill Davidson to board under settlement agreement","bullets":["Jill Davidson appointed as director effective July 26, 2023, expanding board to seven members.","Appointment made pursuant to December 2022 Settlement Agreement with LifeSci Group.","Davidson designated as one of two Company Designees for post-merger board if EIP Pharma merger closes.","Term expires at 2023 annual meeting or when LifeSci Group's net long position falls below 96,976 shares.","Davidson will receive standard non-employee director compensation and enter indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-021201","json":"https://secwatch.observer/filing/0001437749-23-021201.json","markdown":"https://secwatch.observer/filing/0001437749-23-021201.md","text":"https://secwatch.observer/filing/0001437749-23-021201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/0001437749-23-021201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/dffn20230731_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:41:50.048600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c0ee89d85","claim":"Jill Davidson was appointed as director at CervoMed Inc..","evidence_excerpt":"Effective July 26, 2023, the Board of Directors (the “Board”) of Diffusion Pharmaceuticals Inc. (the “Company”) appointed Jill Davidson as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/0001437749-23-021201-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}